AQP4 and injury: The use of the AQP4 modulators in this study was based on previous data from a traumatic brain injury model in mice37 where a single tail vein injection of AqF026 (0.2 mg/kg) and AqB013 (0.8 mg/kg, pharmacologically synonymous to AqB050) successfully reduced cerebral edema.